In the Boardroom
Refine Search
Generics
Novartis has raided GlaxoSmithKline to replace the departed chief executive of the Swiss drugmaker’s Sandoz generics unit. 24 April 2019
Pharmaceutical
Brent Saunders, the chief executive and chairman of Ireland-headquartered drugmaker Allergan, will suddenly be feeling a lot better ahead of the company’s annual meeting of shareholders on May 1. 17 April 2019
Pharmaceutical
Financing and creating enduring confidence around a deal like Takeda’s $62 million purchase of Shire is not straight forward, but the Japanese drugmaker has hired one of the best operators in his field to help with the task. 16 April 2019
Biotechnology
British biotech Kymab has appointed Simon Sturge as its new chief executive, effective 1 May 2019. Mr Sturge will replace David Chiswell, who has been in the role since 2015. 10 April 2019
Pharmaceutical
The nominations committee of Swedish firm Calliditas Therapeutics has proposed that Elmar Schnee becomes a board member and chairman of the company. 5 April 2019
Pharmaceutical
Japanese drug major Astellas Pharma (TYO: $4503) has announced two recent senior-level promotions and one new hire within its Medical and Development (M&D) organization. 4 April 2019
Biotechnology
French privately-held biotech firm Enterome Bioscience has named Jan Fagerberg its new chief medical officer and Catherine Mathis its chief development officer. 3 April 2019
Biotechnology
Daniel Welch, the man who previously headed up several biotechs that were sold to pharma majors over the past several years, has joined privately-held US biopharma company InCarda Therapeutics as executive chairman. 3 April 2019
Pharmaceutical
Botox (onabotulinumtoxinA) manufacturer Allergan has accepted calls to shake up its management structure, agreeing to create a new position to stand alongside the chief executive at the time of the next leadership change. 25 March 2019
Biotechnology
California, USA-based biopharma company Tenaya Therapeutics, which is focused on developing potentially curative treatments for heart disease, today announced that it has strengthened its leadership team. 14 March 2019
Biosimilars
Richard Francis will be stepping down as chief executive of Sandoz, the Novartis generics and biosimilars division, and as a member of the executive committee of Novartis on March 31, 2019. 14 March 2019
Biotechnology
California, USA-based Sangamo Therapeutics has announced the appointment of Jason Fontenot as senior vice president, cell therapy. 13 March 2019
Biotechnology
Privately-held Swiss biotech iOnctura has completed the line-up of its executive leadership team. 12 March 2019
Pharmaceutical
Keld Flintholm Jørgensen has been appointed chief business officer (CBO) heading corporate strategy and business development at Danish CNS specialist Lundbeck. 8 March 2019
Pharmaceutical
Indian drugmaker Glenmark Pharmaceuticals has announced that Alessandro Riva will join its new innovation company as chief executive. The appointment is effective April 2, 2019. 7 March 2019
Biotechnology
Dutch biopharma Kiadis Pharma today announced senior management appointments to further strengthen the company as it transitions into commercial stage. 6 March 2019
Pharmaceutical
USA-based Corbus Pharmaceutical has announced the appointment of Craig Millian to the company as its first chief commercial officer ahead of the potential US Food and Drug Administration approval and commercial launch of its lead drug candidate lenabasum in 2021. 5 March 2019
Pharmaceutical
US-based Sunovion Pharmaceuticals, a subsidiary of Japan’s Sumitomo Dainippon Pharma, has appointed Antony Loebel as president and chief executive. 5 March 2019
Biotechnology
UK-based biotech firm Emergex Vaccines today announces the appointment of Athanasios Papadopoulos as chief medical officer, effective March 1, 2019. 27 February 2019
Biosimilars
A woman who has been involved in biosimilars since work on their development first began two decades ago, has been named director general of the International Generic and Biosimilar medicines Association (IGBA). 21 February 2019
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze